Clinical Trials Browser

Phase 1 × Triple Negative Breast Neoplasms × poly ICLC × Clear all

NCT07300475 2026-02-13

Cancer Immunotherapeutic (PCI) Strategy in Triple Negative Breast Cancer Patients

Phase 1 Not yet recruiting

Triple Negative Breast Neoplasms